Skip to content
Genialis Logo Genialis Logo Genialis Logo
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch

Talking Precision Medicine Podcast

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

Open Media Kit
  • Talking Precision Medicine podcast Episode 28. A new way to finance drug development, for rare diseases and beyond, guest: Alok Tayi, VibeBio
    November 30, 2022

    A new way to finance drug development, for rare disease and beyond with Alok Tayi | Podcast #28

  • Talking Precision Medicine podcast Episode 27. What's in a Name?: Endpoint Health's Patient-Centric Northstar, guest: Jason Springs, Endpoint Health
    June 27, 2022

    What’s in a Name?: Endpoint Health’s Patient-Centric Northstar with Jason Springs | Podcast #27

  • Talking Precision Medicine podcast Episode 26. Taking charge of your health future with wearables and AI, guest: Harry Glorikian
    February 28, 2022

    Taking charge of your health future with wearables and AI with Harry Glorikian | Podcast #26

  • Talking Precision Medicine podcast Episode 25. Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring, guests: Peter Vranes and Hitesh Mehta, Nutromics
    September 5, 2021

    Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring with Peter Vranes and Hitesh Mehta | Podcast #25

  • Talking Precision Medicine podcast Episode 24. Fostering Patient Journeys Around the World, guest: Angeli Moeller, Pharma International Informatics, Roche
    July 28, 2021

    Fostering Patient Journeys Around the World with Angeli Möller | Podcast #24

  • Talking Precision Medicine podcast Episode 23. From Cancer to Covid, Drug Intelligent Science at Breakneck Pace, guest: Liang Schweizer, HiFiBio Therapeutics
    February 26, 2021

    From Cancer to Covid, Drug Intelligent Science at Breakneck Pace with Liang Schweizer | Podcast #23

  • Talking Precision Medicine podcast Episode 22. Ethics and Policies of Precision Medicine on the Global Stage, guest: Elissa Prichep & Cameron Fox, World Economic Forum
    November 19, 2020

    Ethics and Policies of Precision Medicine on the Global Stage with Elissa Prichep and Cameron Fox | Podcast #22

  • Talking Precision Medicine podcast Episode 21. Rebooting generics to fight cancer, guest: Laura Kleiman, Pradeep Mangalath and Catherine Del Vecchio Fitz, Reboot Rx
    August 31, 2020

    Rebooting generics to fight cancer with Laura Kleiman, Pradeep Mangalath and Catherine Del Vecchio Fitz | Podcast #21

  • Talking Precision Medicine podcast Episode 20. Stopping sepsis in its tracks.. oh, and COVID-19 too! Guest: Sarma Velamuri, Luminare
    June 11, 2020

    Stopping sepsis in its tracks… oh, and COVID19 too! with Sarma Velamuri | Podcast #20

Previous123456Next

Genialis, Inc.

68 Harrison Ave #605
PMB 29417
Boston, MA 02111

Get in touch

+1 617 237 0085 (US)
+386 59 054 580 (Slo)
info @ genialis.com
biomarkers @ genialis.com
Genialis LinkedIn

Site map

  • Therapeutic Intelligence & Biomarker Discovery
  • Genialis™ krasID
  • Genialis™ Expressions
  • Why RNA
  • Genialis ResponderID™
  • Genialis™ Supermodel
  • Case Studies
  • Meet Our Team
  • Careers
  • Compliance

Media

  • News and Events
  • Scientific Publications
  • Press Releases
  • Talking Precision Medicine Podcast
Subscribe to our newsletter

Genialis is a founding member of the Alliance for AI in Healthcare

Alliance for Artificial Intelligence in Healthcare AAIH logo
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.

Copyright © Genialis, Inc.

Page load link

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.

Links & Downloads

Genialis Logo
Leadership Headshots
Talking Precision Medicine Info Sheet
Leadership Team
linkedin.com/company/genialis

Media Contact

Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Subscribe to Genialis updates and information

Thanks for subscribing!
There was an error trying to subscribe. Please try again later.
This website uses cookies and third party services. Read More Accept Reject